Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Targeting Clotting Factor VIII Plasma Values in the Perioperative Setting in Hemophilia a: “Tackling a Moving Target” (“OPTI-CLOT” Studies)

Janske Lock, MD PhDstudent, Hendrika C.A.M. Hazendonk, MD PhDstudent, Ron A.A. Mathôt, Prof. Dr., Karina Meijer, MD PhD, Marjolein Peters, MD PhD, Paul Brons, Felix J.M. Van der Meer, MD PhD, Hannan Bouzariouh, MD, Mariette H.E. Driessens, PhD, Karin Fijnvandraat, MD PhD, Frank W.G. Leebeek, MD PhD, Marjon H. Cnossen, MD PhD

Blood (2014) 124 (21): 5031.

https://doi.org/10.1182/blood.V124.21.5031.5031

Published: 2014

Journal Articles

Towards Successful Implementation of Pharmacokinetic-Guided Prophylactic Dosing of Clotting Factor Concentrate in Hemophilia; The Do’s and Don’ts after Discrete Choice Experiment Analysis

Janske Lock, MD PhDstudent, Esther W. de Bekker-Grob, PhD, Gamze Urhan, MD, Saskia Middeldorp, MD PhD, Marjolein Peters, MD PhD, Karina Meijer, MD PhD, Rienk Y.J. Tamminga, MD PhD, Britta Laros-van Gorkum, MD PhD, Paul Brons, Felix J.M. Van der Meer, MD PhD, Mariette H.E. Driessens, PhD, Peter W. Collins, MD, Karin Fijnvandraat, MD PhD, Frank W.G. Leebeek, MD PhD, Marjon H. Cnossen, MD PhD

Blood (2014) 124 (21): 5038.

https://doi.org/10.1182/blood.V124.21.5038.5038

Published: 2014

Journal Articles

Alloantibody Formation In Sickle Cell Disease

Joep Sins, MD, MSc, Saurabh Zalpuri, MD, PhD, Marjon Cnossen, MD, PhD, Anita W. Rijneveld, MD, PhD, Jean-Louis Kerkhoffs, MD, PhD, Alfred van Meurs, MD, Yolanda de Rijke, PhD, Marjolein Peters, MD, PhD, Bart J. Biemond, MD, PhD, Anske van der Bom, MD, PhD, Karin Fijnvandraat, MD, PhD

Blood (2013) 122 (21): 2395.

https://doi.org/10.1182/blood.V122.21.2395.2395

Published: 2013

Journal Articles

Heart Function Disorders In Sickle Cell Disease

Charlotte Heinen, Karin Fijnvandraat, MD, PhD, Marjolein Peters, MD, PhD, Henriette Heijboer, MD, PhD, Nico Blom, MD, PhD, Irene Kuipers, MD, PhD

Blood (2010) 116 (21): 4815.

https://doi.org/10.1182/blood.V116.21.4815.4815

Published: 2010

Journal Articles

Pregnancy Complications In Sickle Cell Disease Are More Prevalent In Women with Vaso-Occlusion Related Organ Damage Than Hemolysis Related Organ Damage

Charlotte F.J. van Tuijn, MSc, Roosmarijn G. van der Stap, MD, Joris A.M. van der Post, MD, PhD, Marjolein Peters, MD, PhD, Bart J. Biemond, MD, PhD

Blood (2010) 116 (21): 2661.

https://doi.org/10.1182/blood.V116.21.2661.2661

Published: 2010

Journal Articles

Mortality and Causes of Death in Children with Sickle Cell Disease in the Netherlands.

Evelyn M. van der Plas, Xandra W. van den Tweel, Harriët Heijboer, Ronald B. Geskus, B. J. Biemond, Marjolein Peters, MD, PhD, Karin Fijnvandraat

Blood (2009) 114 (22): 1519.

https://doi.org/10.1182/blood.V114.22.1519.1519

Published: 2009

Journal Articles

Role of Glycoprotein Ibα Mobility in Platelet Function.

Dianne E van der Wal, Sandra Verhoef, Roger EG Schutgens, Marjolein Peters, MD, PhD, Jan-Willem Akkerman, PhD

Blood (2008) 112 (11): 1850.

https://doi.org/10.1182/blood.V112.11.1850.1850

Published: 2008

Journal Articles

Development and Validation of a Pediatric Severity Index for Sickle Cell Patients.

Xandra W. van den Tweel, MD, Johanna H. van der Lee, MD, Harriët Heijboer, MD PhD, Marjolein Peters, MD PhD, Karin Fijnvandraat, MD PhD

Blood (2007) 110 (11): 3391.

https://doi.org/10.1182/blood.V110.11.3391.3391

Published: 2007

NARROW

Targeting Clotting Factor VIII Plasma Values in the Perioperative Setting in Hemophilia a: “Tackling a Moving Target” (“OPTI-CLOT” Studies)

Towards Successful Implementation of Pharmacokinetic-Guided Prophylactic Dosing of Clotting Factor Concentrate in Hemophilia; The Do’s and Don’ts after Discrete Choice Experiment Analysis

Alloantibody Formation In Sickle Cell Disease

Heart Function Disorders In Sickle Cell Disease

Pregnancy Complications In Sickle Cell Disease Are More Prevalent In Women with Vaso-Occlusion Related Organ Damage Than Hemolysis Related Organ Damage

Mortality and Causes of Death in Children with Sickle Cell Disease in the Netherlands.

Role of Glycoprotein Ibα Mobility in Platelet Function.

Development and Validation of a Pediatric Severity Index for Sickle Cell Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only